Endo Int'l Shares Retake Mon. Morning Highs, Up 10.4% Tues.; Stock Did Not React To Report State Attorney Generals Have Expanded Suit Alleging Price Fixing By Generic Drugmakers; Co. Issued Strong Guidance Mon. Morning